-
公开(公告)号:US5780263A
公开(公告)日:1998-07-14
申请号:US468847
申请日:1995-06-06
申请人: Gregg A. Hastings , Mark D. Adams
发明人: Gregg A. Hastings , Mark D. Adams
IPC分类号: A61K38/00 , C07K14/475 , C12N15/12
CPC分类号: C07K14/475 , A61K38/00
摘要: A human Small CCN-Like Growth Factor polypeptide (SCGF) and DNA (RNA) encoding such polypeptide and a procedure for producing such polypeptide by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptide for wound healing or tissue regeneration, stimulating implant fixation and angiogenesis. Antagonist against such polypeptides and their use as a therapeutic to treat atherosclerosis, tumors and scarring are also disclosed. Diagnostic assays for identifying mutations in SCGF nucleic acid sequences and altered levels of the SCGF polypeptide are also disclosed.
-
公开(公告)号:US07485459B2
公开(公告)日:2009-02-03
申请号:US10788346
申请日:2004-03-01
IPC分类号: C12N5/22 , A61K39/395 , C07K16/28
CPC分类号: C07K14/47 , A61K38/00 , Y02A50/411
摘要: A human F-spondin-like protein and DNA (RNA) encoding such protein and a procedure for producing such protein by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptide for treating spinal cord injuries and damage to peripheral nerves by promoting neural-cell adhesion and neurite extension, inhibiting tumor metastases and tumor angiogenesis, and stimulating wound repair. Antagonists are also disclosed which may be utilized to prevent malaria. Diagnostic assays for identifying mutations in nucleic acid sequence encoding a polypeptide of the present invention and for detecting altered levels of the polypeptide of the present invention for detecting diseases, for example, cancer, are also disclosed.
摘要翻译: 公开了一种编码这种蛋白质的人类F-脊椎样蛋白样蛋白和DNA(RNA)以及通过重组技术产生这种蛋白质的方法。 还公开了通过促进神经细胞粘附和神经突延伸,抑制肿瘤转移和肿瘤血管发生以及刺激伤口修复来利用这种多肽来治疗脊髓损伤和损伤周围神经的方法。 还公开了可用于预防疟疾的拮抗剂。 还公开了用于鉴定编码本发明多肽的核酸序列中的突变并用于检测用于检测疾病例如癌症的本发明多肽的改变水平的诊断测定法。
-
公开(公告)号:US20080317754A1
公开(公告)日:2008-12-25
申请号:US11756638
申请日:2007-06-01
申请人: Gregg A. Hastings , Mark D. Adams , Claire M. Fraser , Norman H. Lee , Ewen F. Kirkness , Judith A. Blake , Lisa M. Fitzgerald , Fred H. Drake , Maxine Gowan
发明人: Gregg A. Hastings , Mark D. Adams , Claire M. Fraser , Norman H. Lee , Ewen F. Kirkness , Judith A. Blake , Lisa M. Fitzgerald , Fred H. Drake , Maxine Gowan
IPC分类号: A61K39/395 , C12N15/11 , C12N15/00 , C12N1/20 , C12P21/04 , G01N33/53 , A61P31/00 , C12N9/50 , C07K16/18 , A61K38/43 , A61K31/7088
CPC分类号: C12N9/6472 , A61K38/00 , C07K16/40
摘要: Disclosed is a human osteoclast-derived cathepsin (Cathepsin O) polypeptide and DNA(RNA) encoding such cathepsin O polypeptides. Also provided is a procedure for producing such polypeptide by recombinant techniques. The present invention also discloses antibodies, antagonists and inhibitors of such polypeptide which may be used to prevent the action of such polypeptide and therefore may be used therapeutically to treat bone diseases such as osteoporosis and cancers, such as tumor metastases.
摘要翻译: 公开了一种人破骨细胞来源的组织蛋白酶(组织蛋白酶O)多肽和编码这种组织蛋白酶O多肽的DNA(RNA)。 还提供了通过重组技术产生这种多肽的方法。 本发明还公开了这种多肽的抗体,拮抗剂和抑制剂,其可用于预防这种多肽的作用,因此可用于治疗性治疗骨疾病如骨质疏松症和癌症如肿瘤转移。
-
公开(公告)号:US06387682B1
公开(公告)日:2002-05-14
申请号:US08798096
申请日:1997-02-12
申请人: Gregg A. Hastings , Mark D. Adams , Claire M. Fraser , Norman H. Lee , Ewen F. Kirkness , Judith A. Blake , Lisa M. Fitzgerald , Fred H. Drake , Maxine Gowan
发明人: Gregg A. Hastings , Mark D. Adams , Claire M. Fraser , Norman H. Lee , Ewen F. Kirkness , Judith A. Blake , Lisa M. Fitzgerald , Fred H. Drake , Maxine Gowan
IPC分类号: C12N964
CPC分类号: C12N9/6472 , A61K38/00 , C07K16/40
摘要: Disclosed is a human osteoclast-derived cathepsin (Cathepsin O) polypeptide and DNA(RNA) encoding such cathepsin O polypeptides. Also provided is a procedure for producing such polypeptide by recombinant techniques. The present invention also discloses antibodies, antagonists and inhibitors of such polypeptide which may be used to prevent the action of such polypeptide and therefore may be used therapeutically to treat bone diseases such as osteoporosis and cancers, such as tumor metastases.
-
公开(公告)号:US06383793B1
公开(公告)日:2002-05-07
申请号:US08915095
申请日:1997-08-20
申请人: Gregg A. Hastings , Mark D. Adams , Claire M. Fraser , Norman H. Lee , Ewen F. Kirkness , Judith A. Blake , Lisa M. Fitzgerald , Fred H. Drake , Maxine Gowan
发明人: Gregg A. Hastings , Mark D. Adams , Claire M. Fraser , Norman H. Lee , Ewen F. Kirkness , Judith A. Blake , Lisa M. Fitzgerald , Fred H. Drake , Maxine Gowan
IPC分类号: C12N964
CPC分类号: C12N9/6472 , A61K38/00 , C07K16/40
摘要: Disclosed is a human osteoclast-derived cathepsin (Cathepsin O) polypeptide and DNA(RNA) encoding such cathepsin O polypeptides. Also provided is a procedure for producing such polypeptide by recombinant techniques. The present invention also discloses antibodies, antagonists and inhibitors of such polypeptide which may be used to prevent the action of such polypeptide and therefore may be used therapeutically to treat bone diseases such as osteoporosis and cancers, such as tumor metastases.
摘要翻译: 公开了一种人破骨细胞来源的组织蛋白酶(组织蛋白酶O)多肽和编码这种组织蛋白酶O多肽的DNA(RNA)。 还提供了通过重组技术产生这种多肽的方法。 本发明还公开了这种多肽的抗体,拮抗剂和抑制剂,其可用于预防这种多肽的作用,因此可用于治疗性治疗骨疾病如骨质疏松症和癌症如肿瘤转移。
-
公开(公告)号:US08017349B2
公开(公告)日:2011-09-13
申请号:US12364360
申请日:2009-02-02
IPC分类号: G01N33/68 , G01N33/563 , G01N33/577
CPC分类号: C07K14/47 , A61K38/00 , Y02A50/411
摘要: A human F-spondin-like protein and DNA (RNA) encoding such protein and a procedure for producing such protein by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptide for treating spinal cord injuries and damage to peripheral nerves by promoting neural-cell adhesion and neurite extension, inhibiting tumor metastases and tumor angiogenesis, and stimulating wound repair. Antagonists are also disclosed which may be utilized to prevent malaria. Diagnostic assays for identifying mutations in nucleic acid sequence encoding a polypeptide of the present invention and for detecting altered levels of the polypeptide of the present invention for detecting diseases, for example, cancer, are also disclosed.
摘要翻译: 公开了一种编码这种蛋白质的人类F-脊椎样蛋白样蛋白和DNA(RNA)以及通过重组技术产生这种蛋白质的方法。 还公开了通过促进神经细胞粘附和神经突延伸,抑制肿瘤转移和肿瘤血管发生以及刺激伤口修复来利用这种多肽来治疗脊髓损伤和损伤周围神经的方法。 还公开了可用于预防疟疾的拮抗剂。 还公开了用于鉴定编码本发明多肽的核酸序列中的突变并用于检测用于检测疾病例如癌症的本发明多肽的改变水平的诊断测定法。
-
公开(公告)号:US07235371B2
公开(公告)日:2007-06-26
申请号:US11185877
申请日:2005-07-21
申请人: Gregg A. Hastings , Mark D. Adams , Claire M. Fraser , Norman H. Lee , Ewen F. Kirkness , Judith A. Blake , Lisa M. Fitzgerald , Fred H. Drake , Maxine Gowan
发明人: Gregg A. Hastings , Mark D. Adams , Claire M. Fraser , Norman H. Lee , Ewen F. Kirkness , Judith A. Blake , Lisa M. Fitzgerald , Fred H. Drake , Maxine Gowan
CPC分类号: C12N9/6472 , A61K38/00 , C07K16/40
摘要: Disclosed is a human osteoclast-derived cathepsin (Cathepsin O) polypeptide and DNA(RNA) encoding such cathepsin O polypeptides. Also provided is a procedure for producing such polypeptide by recombinant techniques. The present invention also discloses antibodies, antagonists and inhibitors of such polypeptide which may be used to prevent the action of such polypeptide and therefore may be used therapeutically to treat bone diseases such as osteoporosis and cancers, such as tumor metastases.
摘要翻译: 公开了一种人破骨细胞来源的组织蛋白酶(组织蛋白酶O)多肽和编码这种组织蛋白酶O多肽的DNA(RNA)。 还提供了通过重组技术产生这种多肽的方法。 本发明还公开了这种多肽的抗体,拮抗剂和抑制剂,其可用于预防这种多肽的作用,因此可用于治疗性治疗骨疾病如骨质疏松症和癌症如肿瘤转移。
-
公开(公告)号:US07220557B2
公开(公告)日:2007-05-22
申请号:US09373658
申请日:1999-08-13
申请人: Gregg A. Hastings , Zdenka L. Jonak , Stephen H. Trulli , James A. Fornwald , Jonathan A. Terrett
发明人: Gregg A. Hastings , Zdenka L. Jonak , Stephen H. Trulli , James A. Fornwald , Jonathan A. Terrett
CPC分类号: C07K14/4702 , A61K38/00 , A61K48/00 , C07K14/78 , C07K2319/00 , C12N9/6489 , C12N2799/026
摘要: The present invention relates to novel anti-angiogenic proteins, related to thrombospondin. More specifically, isolated nucleic acid molecules are provided encoding human METH1 and METH2. METH1 and METH2 polypeptides are also provided, as are vectors, host cells and recombinant methods for producing the same. Also provided are diagnostic methods for the prognosis of cancer and therapeutic methods for treating individuals in need of an increased amount of METH1 or METH2. Also provided are methods for inhibiting angiogenesis using METH1 or METH2.
摘要翻译: 本发明涉及与血小板反应蛋白相关的新型抗血管生成蛋白。 更具体地,提供编码人METH1和METH2的分离的核酸分子。 还提供了METH1和METH2多肽,以及载体,宿主细胞和用于制备它们的重组方法。 还提供了用于预测癌症的诊断方法和用于治疗需要增加量的METH1或METH2的个体的治疗方法。 还提供了使用METH1或METH2抑制血管生成的方法。
-
公开(公告)号:US07153670B2
公开(公告)日:2006-12-26
申请号:US10960275
申请日:2004-10-08
申请人: Gregg A. Hastings , Gene Liau , Elena Tsifrina
发明人: Gregg A. Hastings , Gene Liau , Elena Tsifrina
CPC分类号: G01N33/5008 , C07K14/705 , G01N33/502 , G01N33/68 , G01N2333/47
摘要: The present invention relates to full-length WF-HABP, WF-HABP, OE-HABP, and BM-HABP, members of the hyaluronan receptor family. The invention provides isolated nucleic acid molecules encoding human to full-length WF-HABP, WF-HABP, OE-HABP, and BM-HABP receptors. Full-length WF-HABP, WF-HABP, OE-HABP, and BM-HABP polypeptides are also provided, as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of full-length WF-HABP, WF-HABP, OE-HABP, and BM-HABP receptor activity. Also provided are diagnostic methods for detecting disease states related to the aberrant expression of full-length WF-HABP, WF-HABP, OE-HABP, and BM-HABP receptors. Further provided are therapeutic methods for treating disease states including, but not limited to, proliferative conditions, metastasis, inflammation, ischemia, host defense dysfunction, immune surveillance dysfunction, arthritis, multiple sclerosis, autoimmunity, immune dysfunction, and allergy.
摘要翻译: 本发明涉及透明质酸受体家族的全长WF-HABP,WF-HABP,OE-HABP和BM-HABP。 本发明提供了编码人全长WF-HABP,WF-HABP,OE-HABP和BM-HABP受体的分离的核酸分子。 还提供了全长WF-HABP,WF-HABP,OE-HABP和BM-HABP多肽,载体,宿主细胞和用于制备它们的重组方法也是如此。 本发明还涉及用于鉴定全长WF-HABP,WF-HABP,OE-HABP和BM-HABP受体活性的激动剂和拮抗剂的筛选方法。 还提供了用于检测与全长WF-HABP,WF-HABP,OE-HABP和BM-HABP受体的异常表达相关的疾病状态的诊断方法。 进一步提供治疗疾病状态的治疗方法,包括但不限于增殖性病症,转移,炎症,缺血,宿主防御功能障碍,免疫监视功能障碍,关节炎,多发性硬化,自身免疫,免疫功能障碍和过敏。
-
公开(公告)号:US06994978B2
公开(公告)日:2006-02-07
申请号:US10726645
申请日:2003-12-04
申请人: Gregg A. Hastings , Mark D. Adams , Claire M. Fraser , Norman H. Lee , Ewen F. Kirkness , Judith A. Blake , Lisa M. Fitzgerald , Fred H. Drake , Maxine Gowan
发明人: Gregg A. Hastings , Mark D. Adams , Claire M. Fraser , Norman H. Lee , Ewen F. Kirkness , Judith A. Blake , Lisa M. Fitzgerald , Fred H. Drake , Maxine Gowan
CPC分类号: C12N9/6472 , A61K38/00 , C07K16/40
摘要: Disclosed is a human osteoclast-derived cathepsin (Cathepsin O) polypeptide and DNA(RNA) encoding such cathepsin O polypeptides. Also provided is a procedure for producing such polypeptide by recombinant techniques. The present invention also discloses antibodies, antagonists and inhibitors of such polypeptide which may be used to prevent the action of such polypeptide and therefore may be used therapeutically to treat bone diseases such as osteoporosis and cancers, such as tumor metastases.
-
-
-
-
-
-
-
-
-